Evaluating the role of single-arm trials in oncology decision-making: an interview with Sorrel Wolowacz, RTI Health Solutions

23 Feb 2023

Written by Sorrel Wolowacz (RTI Health Solutions)

Health technology assessment Interviews ISPOR Look behind the lecture Oncology and hematology Trial methodologies

In this interview with Sorrel Wolowacz (Head, European Health Economics, RTI Health Solutions, UK) we discuss the topic of the ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2022 Issue Panel on the use of single-arm trials in oncology, and evidence generation for health technology assessment (HTA) decisions. Please could you introduce yourself and your role, and why the topic of single-arm trials (SATs) was an important one to cover at ISPOR Europe 2022? Hi, I am Dr. Sorrel Wolowacz, Head of European Health Economics at RTI Health Solutions and a Member Engagement Chair for the ISPOR Oncology Special...